Bausch Health Companies | VRX - Ordinary Share Capital


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Bausch Health Companies

Bausch Health Companies Inc reported $10.4B in Ordinary Share Capital for its fiscal quarter ending in March of 2023.


Ordinary Share Capital Change
ANI Pharmaceuticals ANIP:US USD 1000 0
Bausch Health Companies Inc VRX:CN USD 10.4B 14M
Catalent CTLT:US USD 2M 0
Corcept Therapeutics CORT:US USD 131K 0
Danaher DHR:US USD 9M 0
Drreddys Laboratories RDY:US INR 833M 0
Eli Lilly LLY:US USD 593.5M 600K
Endo International ENDP:US USD 67K 0
Horizon Pharma HZNP:US USD 23K 0
Nektar Therapeutics NKTR:US USD 19K 0
Pacira PCRX:US USD 46K 0
Perrigo PRGO:US USD 6.91B 25.9M
Phibro Animal Health PAHC:US USD 4K 0
Prestige Brands PBH:US USD 548K 0
Revance Therapeutics RVNC:US USD 84K 2K
Supernus Pharmaceuticals SUPN:US USD 54K 0
Vertex Pharmaceuticals VRTX:US USD 2.6M 0
Zoetis ZTS:US USD 5M 0